Edition:
United Kingdom

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

38.82USD
23 May 2018
Change (% chg)

$-0.07 (-0.18%)
Prev Close
$38.89
Open
$38.64
Day's High
$38.91
Day's Low
$38.63
Volume
419,568
Avg. Vol
810,976
52-wk High
$46.80
52-wk Low
$35.10

Select another date:

Thu, May 3 2018

BRIEF-Hologic Receives Health Canada Authorization To Market Sculpsure Laser

* HOLOGIC RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE® LASER FOR NON-INVASIVE BODY CONTOURING (LIPOLYSIS) OF THE BACK, INNER AND OUTER THIGHS, AND UNDER THE CHIN Source text for Eikon: Further company coverage:

BRIEF-Hologic Q2 GAAP Loss Per Share $2.46

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2018

BRIEF-FDA Approval Of Thinprep Integrated Imager Expands Automated Imaging For Pap Testing To More Labs

* FDA APPROVAL OF THINPREP® INTEGRATED IMAGER EXPANDS AUTOMATED IMAGING FOR PAP TESTING TO MORE LABS

BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes Review

* ENZO BIOCHEM INC - PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW Source text for Eikon: Further company coverage:

BRIEF-FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System

* FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1)

BRIEF-Koninklijke Philips And Hologic Announce Global Partnership Agreement

* PHILIPS AND HOLOGIC ANNOUNCE GLOBAL PARTNERSHIP AGREEMENT TO PROVIDE INTEGRATED IMAGING SOLUTIONS FOR WOMEN'S HEALTH

BRIEF-Hologic Reports Q1 GAAP Earnings Per Share $1.45

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018

BRIEF-Hologic - CEO's 2017 Total Compensation Was $11.2 Million Vs $10.8 Million‍​

* HOLOGIC INC - CEO STEPHEN P. MACMILLAN'S 2017 TOTAL COMPENSATION WAS $11.2 MILLION VERSUS $10.8 MILLION - SEC FILING‍​ Source text: (http://bit.ly/2nhdmKL) Further company coverage:

BRIEF-Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system

* THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM

Select another date: